XML 27 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF PREFERRED STOCK AND STOCKHOLDERS’ (DEFICIT) EQUITY - USD ($)
$ in Thousands
Total
Cumulative-effect adjustment
Series F warrants
Class S Stock
Redeemable Convertible Preferred Stock
Series J Warrants
Class S Stock
Class S Stock
Class S Stock
Common Stock
Common Stock
Series F warrants
Common Stock
Class S Stock
Common Stock
Redeemable Convertible Preferred Stock
Common Stock
Series J Warrants
Additional Paid-in Capital
Additional Paid-in Capital
Series F warrants
Additional Paid-in Capital
Redeemable Convertible Preferred Stock
Additional Paid-in Capital
Series J Warrants
Loans to Related Parties
Accumulated Deficit
Accumulated Deficit
Cumulative-effect adjustment
Beginning balance (in shares) at Dec. 27, 2020 62,562,051                                      
Beginning balance at Dec. 27, 2020 $ 505,638                                      
Increase (Decrease) in Temporary Equity [Roll Forward]                                        
Issuance of preferred stock (in shares) 6,669,146                                      
Issuance of preferred stock $ 108,858                                      
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering (in shares) (69,231,197)                                      
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering $ (614,496)                                      
Ending balance (in shares) at Dec. 26, 2021 0                                      
Ending balance at Dec. 26, 2021 $ 0                                      
Beginning balance (in shares) at Dec. 27, 2020             0   16,731,625                      
Beginning balance at Dec. 27, 2020 (307,362)           $ 0   $ 17         $ 19,662       $ (4,000) $ (323,041)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                        
Net loss (153,175)                                   (153,175)  
Stock-based compensation expense 28,897                         28,897            
Issuance of common stock related to restricted shares (in shares)                 15,000                      
Exercise of stock options (in shares)                 5,247,279                      
Exercise of stock options 26,028               $ 5         26,023            
Exercise of common stock warrants (in shares)                 61,147                      
Exercise of common stock warrants 119                         119            
Issuance of Class S stock for acquisition of business (in shares)             1,843,493                          
Issuance of Class S stock for acquisition of business 30,703           $ 2             30,703            
Issuance of stock (in shares)                 14,950,000                      
Issuance of stock 384,692               $ 15         384,677            
Preferred stock automatically converted (in shares)               (1,843,493)   (235,000) (1,316,763) (69,231,197) (1,557,686)              
Conversion of convertible securities     $ 6,580 $ 1 $ 614,496 $ 16,979   $ (2)     $ 1 $ 69 $ 2   $ 6,580 $ 614,427 $ 16,977      
Repayment of related party loan 5,159                         1,159       4,000    
Ending balance (in shares) at Dec. 26, 2021             0   109,345,697                      
Ending balance at Dec. 26, 2021 $ 653,117 $ (4,944)         $ 0   $ 109         1,129,224       0 (476,216) $ (4,944)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                        
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2016-02 [Member]                                      
Net loss $ (190,441)                                   (190,441)  
Stock-based compensation expense 78,736                         78,736            
Issuance of common stock related to restricted shares (in shares)                 829,679                      
Issuance of common stock related to restricted shares $ 0               $ 1         (1)            
Exercise of stock options (in shares) 957,617               957,617                      
Exercise of stock options $ 4,758               $ 1         4,757            
Ending balance (in shares) at Dec. 25, 2022             0   111,132,993                      
Ending balance at Dec. 25, 2022 $ 541,226           $ 0   $ 111         1,212,716       0 (671,601)  
Ending balance (in shares) at Dec. 31, 2023 0                                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                        
Net loss $ (113,384)                                   (113,384)  
Stock-based compensation expense $ 49,532                         49,532            
Issuance of common stock related to restricted shares (in shares)                 587,078                      
Exercise of stock options (in shares) 929,963               929,963                      
Exercise of stock options $ 5,389               $ 2         5,387            
Shares repurchased for employee tax withholding (in shares)                 (10,888)                      
Shares repurchased for employee tax withholding (166)                         (166)            
Ending balance (in shares) at Dec. 31, 2023             0   112,639,146                      
Ending balance at Dec. 31, 2023 $ 482,597           $ 0   $ 113         $ 1,267,469       $ 0 $ (784,985)